Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids

流感疫苗制剂在人体免疫类器官中介导不同的细胞和抗体反应

阅读:6
作者:Jenna M Kastenschmidt ,Suhas Sureshchandra ,Aarti Jain ,Jenny E Hernandez-Davies ,Rafael de Assis ,Zachary W Wagoner ,Andrew M Sorn ,Mahina Tabassum Mitul ,Aviv I Benchorin ,Elizabeth Levendosky ,Gurpreet Ahuja ,Qiu Zhong ,Douglas Trask ,Jacob Boeckmann ,Rie Nakajima ,Algimantas Jasinskas ,Naresha Saligrama ,D Huw Davies ,Lisa E Wagar

Abstract

Highly effective vaccines elicit specific, robust, and durable adaptive immune responses. To advance informed vaccine design, it is critical that we understand the cellular dynamics underlying responses to different antigen formats. Here, we sought to understand how antigen-specific B and T cells were activated and participated in adaptive immune responses within the mucosal site. Using a human tonsil organoid model, we tracked the differentiation and kinetics of the adaptive immune response to influenza vaccine and virus modalities. Each antigen format elicited distinct B and T cell responses, including differences in their magnitude, diversity, phenotype, function, and breadth. These differences culminated in substantial changes in the corresponding antibody response. A major source of antigen format-related variability was the ability to recruit naive vs. memory B and T cells to the response. These findings have important implications for vaccine design and the generation of protective immune responses in the upper respiratory tract.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。